Rex, J H <br/><br/>
In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.  [electronic resource] 

 -  The Journal of infectious diseases  Apr 1991 
 - 849-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1093/infdis/163.4.849  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Aspergillus fumigatus--immunology<br/>Double-Blind Method<br/>Granulomatous Disease, Chronic--immunology<br/>Humans<br/>Interferon-gamma--therapeutic use<br/>Neutrophils--immunology<br/>Recombinant Proteins